Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive after releasing full year results for calendar year 2022 - a year he describes as "terrific" for the endoscopy-focused medical device company.
Gulliford also gives the highlights from the post-period, which included an oversubscribed £33.7mln gross fundraise in March of 2023, and says Creo "knows what [it] needs to do" moving forward.
